Capital Fund Management S.A. Myovant Sciences Ltd. Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$14.31 - $23.87 $319,599 - $533,112
-22,334 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$18.94 - $26.99 $110,723 - $157,783
5,846 Added 35.46%
22,334 $501,000
Q2 2021

Aug 12, 2021
BUY
$17.07 - $24.56 $281,450 - $404,945
16,488 New
16,488 $375,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email